Journal article
M. Gregory, Sarah Macewan, Jonathan R Powell, Jaclyn Volney, Jordan D. Kurth, E. Kenah, A. Panchal, A. McAlearney
Human Vaccines & Immunotherapeutics, 2022
Human Vaccines & Immunotherapeutics, 2022
Semantic Scholar
DOI
PubMedCentral
PubMed
Cite
Cite
APA
Click to copy
Gregory, M., Macewan, S., Powell, J. R., Volney, J., Kurth, J. D., Kenah, E., … McAlearney, A. (2022). The COVID-19 vaccine concerns scale: Development and validation of a new measure. Human Vaccines &Amp; Immunotherapeutics.
Chicago/Turabian
Click to copy
Gregory, M., Sarah Macewan, Jonathan R Powell, Jaclyn Volney, Jordan D. Kurth, E. Kenah, A. Panchal, and A. McAlearney. “The COVID-19 Vaccine Concerns Scale: Development and Validation of a New Measure.” Human Vaccines & Immunotherapeutics (2022).
MLA
Click to copy
Gregory, M., et al. “The COVID-19 Vaccine Concerns Scale: Development and Validation of a New Measure.” Human Vaccines &Amp; Immunotherapeutics, 2022.
BibTeX Click to copy
@article{m2022a,
title = {The COVID-19 vaccine concerns scale: Development and validation of a new measure},
year = {2022},
journal = {Human Vaccines & Immunotherapeutics},
author = {Gregory, M. and Macewan, Sarah and Powell, Jonathan R and Volney, Jaclyn and Kurth, Jordan D. and Kenah, E. and Panchal, A. and McAlearney, A.}
}
Abstract
ABSTRACT Reasons for COVID-19 hesitancy are multi-faceted and tend to differ from those for general vaccine hesitancy. We developed the COVID-19 Vaccine Concerns Scale (CVCS), a self-report measure intended to better understand individuals’ concerns about COVID-19 vaccines. We validated the scale using data from a convenience sample of 2,281 emergency medical services providers, a group of professionals with high occupational COVID-19 risk. Measures included the CVCS items, an adapted Oxford COVID-19 vaccine hesitancy scale, a general vaccine hesitancy scale, demographics, and self-reported COVID-19 vaccination status. The CVCS had high internal consistency reliability (α = .89). A one-factor structure was determined by exploratory and confirmatory factor analyses (EFA and CFA), resulting in a seven-item scale. The model had good fit (X2[14] = 189.26, p < .001; CFI = .95, RMSEA = .11 [.09, .12], NNFI = .93, SRMR = .03). Moderate Pearson correlations with validated scales of general vaccine hesitancy (r = .71 , p < .001; n = 2144) and COVID-19 vaccine hesitancy (r = .82; p < .001; n = 2279) indicated construct validity. The CVCS predicted COVID-19 vaccination status (B = −2.21, Exp(B) = .11 [95% CI = .09, .13], Nagelkerke R2 = .55), indicating criterion-related validity. In sum, the 7-item CVCS is a reliable and valid self-report measure to examine fears and concerns about COVID-19 vaccines. The scale predicts COVID-19 vaccination status and can be used to inform efforts to reduce COVID-19 vaccine hesitancy.
